Telix Pharmaceuticals | TLX - Ativos

Preço das Ações
12.75
Mudança Diária
0.34 2.74%
Mensal
32.67%
Anual
-54.43%
Q1 Previsão
12.48




Ativos Alterar Data
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesoblast USD 782.31M 2.38M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Pacific Edge NZD 34.66M 2.37M 2025-12
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12